Releases - Elekta

View:
 

Found press releases

 

The US Oncology Network to Standardize on Elekta’s MOSAIQ Oncology Information S...

The US Oncology Network (The Woodlands, Texas) – among the largest networks of community-based oncology physicians in the United States – has selected Elekta’s MOSAIQ® Oncology Information System (OIS) as the standard radiation oncology OIS across The Network. In the agreement, The Network committed to purchase five Elekta...

Invitation to Elekta’s full-year report conference call

Elekta will publish its full-year report for 2011/12 on June 5, 2012 with the following schedule:

· The report will be published at 07:30 CET.
· Elekta will host a telephone conference at 10:00-11:00 CET, with Tomas Puusepp, President and CEO and Håkan Bergström, CFO.

To take part in the conference call, please dial in about 5-10 minutes in advance and use the access code 917247.

· Swedish dial-in number: +46...

Elekta pioneers modern cancer care through R&D leadership

More than 13 million new cancer cases occur globally every year, of which 3 million are in Europe, according to the World Health Organization. And as the population ages, the number of cancer cases is expected to rise. Through patient-focused research and development initiatives, Elekta’s goal is to make treatment more available and promising for these people. Elekta’s President and CEO, Tomas Puusepp, recently...

Invitation to Elekta’s Capital Markets Day – June 19, 2012 in Stockholm

Stockholm, May 3, 2012

Elekta invites equity analysts, investors and media representatives to a Capital Markets Day in Stockholm, June 19. Tomas Puusepp, President and CEO, and other members of Elekta’s management team will give presentations focusing on Elekta’s strategy and development. Lunch will be served from 12:15 CET and the presentations will start at 13:00 and end at approximately 15:30. The venue is Grand...

Number of outstanding shares in Elekta AB (publ)

During April, 23,141 new B shares were issued in Elekta through the exercise of warrants distributed within the framework of the established option program.

The total number of shares in Elekta as of April 30, 2012 amounts to 95,249,816 divided between 3,562,500 A shares and 91,687,316 B shares.

One A share entitles the holder to ten votes and one B share to one vote.

For further information, please...
 

Elekta Announces First Patients Treated with Major Breakthrough in Cancer Therap...

St. James’s University Hospital (Leeds, UK) debuts clinical use of Agility multileaf collimator (MLC)

LEEDS, England, April 19 – Using Agility™*, Elekta’s latest MLC innovation, patients at St. James’s University Hospital were the first in the world to benefit from this modern advancement in the treatment of cancer. With twice the number of leaves typical of many standard MLCs, Agility precisely sculpts delivered...
 

Elekta’s New Agility MLC Solution Poised to Revolutionize Beam Shaping of Radiat...

Elekta has received clearance to CE mark its new multileaf collimator (MLC)
Crawley, England, April 2 – Elekta announced today it has received clearance to CE mark Agility™*, a revolutionary beam-shaping device integrated into the head of a linear accelerator (linac). Patients and clinics will benefit from the speed and reliability of this new MLC design.

“According to WHO, cancer is a leading cause of death...

Number of outstanding shares in Elekta AB (publ)

During March, 373,131 new B shares were issued in Elekta through the exercise of warrants distributed within the framework of the established option program.

The total number of shares in Elekta as of March 30, 2012 amounts to 95,226,675 divided between 3,562,500 A shares and 91,644,175 B shares.

One A share entitles the holder to ten votes and one B share to one vote.

For further information, please...

Gamma Knife Radiosurgery Gets Nod in Guinness World Records 2012 Edition for Hal...

ATLANTA, March 16 /PRNewswire/ – Sultan Kosen won’t be posting new world records for height anymore, but that’s just fine with him. The Gamma Knife® radiosurgery the 29-year-old Turkish man had in August 2010 has successfully stopped his growth at the height of 8 ft 3 in (251 cm). Mr. Kosen, who suffered the effects of acromegaly, has held the title of “World’s Tallest Living Human” since September 2009, when his 8...

Interim report May – January 2011/12


· Order bookings increased to SEK 7,186 M (6,041), equivalent to 9* percent calculated excluding Nucletron.
· Net sales increased to SEK 5,929 M (5,328), equivalent to 5* percent calculated  excluding Nucletron.
· Operating result amounted to SEK 967 M (751) before non-recurring items of SEK 107 M (−) (see page 4).
· Net income amounted to SEK 687 M (500). Earnings per share amounted to SEK 7.31 (5.37) before...

Elekta

Elekta is a leading international medical-technology company offering advanced and innovative clinical solutions and services for precision radiation treatment of cancer and minimally invasive treatment of brain disorder...

View more


  CONTACT  
  • Stina Thorman
  • Vice President Corporate Communications
  • +46 8 587 254 37
  •